[Pharmacologic basis of the effectiveness of topotecan in the treatment of ovarian carcinoma].
Zunino
F
F
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italia.
Perego
P
P
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D019772:Topotecan / Q000494:pharmacology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019772:Topotecan